HYAL1 and prostate carcinoma: Researchers have further delineated the intracellular trafficking route of HYAL1 in prostate cancer cells: the enzyme is initially secreted into the extracellular space via the classical ER-Golgi pathway, then re-internalized through endocytosis and incorporated into the vesicular sorting system [21].